Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Glue, Grease, and Container: A Simplified Take on Administrative Skills.

Lesser IM.

Acad Psychiatry. 2016 Jun;40(3):413-4. doi: 10.1007/s40596-015-0452-4. Epub 2015 Oct 30. No abstract available.

PMID:
26515083
2.

Presence of antibrain antibodies in obsessive-compulsive disorder secondary to pineal gland germinoma: a case report.

Zhu W, Burgoyne KS, Lesser IM.

Psychosomatics. 2014 Nov-Dec;55(6):729-34. doi: 10.1016/j.psym.2014.05.001. Epub 2014 May 6. No abstract available.

PMID:
25262037
3.

Response to citalopram is not associated with SLC6A4 genotype in African-Americans and Caucasians with major depression.

Poland RE, Lesser IM, Wan YJ, Gertsik L, Yao J, Raffel LJ, Lin KM, Myers HF.

Life Sci. 2013 May 30;92(20-21):967-70. doi: 10.1016/j.lfs.2013.03.009. Epub 2013 Apr 3.

4.

Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.

Zisook S, Lesser IM, Lebowitz B, Rush AJ, Kallenberg G, Wisniewski SR, Nierenberg AA, Fava M, Luther JF, Morris DW, Trivedi MH.

J Clin Psychiatry. 2011 Oct;72(10):1322-32. doi: 10.4088/JCP.10m06724.

PMID:
22075098
5.

Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial.

Lesser IM, Zisook S, Gaynes BN, Wisniewski SR, Luther JF, Fava M, Khan A, McGrath P, Warden D, Rush AJ, Trivedi M.

Psychiatr Serv. 2011 Oct;62(10):1167-79. doi: 10.1176/ps.62.10.pss6210_1167.

PMID:
21969643
6.

Support and undermining in interpersonal relationships are associated with symptom improvement in a trial of antidepressant medication.

Joseph NT, Myers HF, Schettino JR, Olmos NT, Bingham-Mira C, Lesser IM, Poland RE.

Psychiatry. 2011 Fall;74(3):240-54. doi: 10.1521/psyc.2011.74.3.240.

7.

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

Bobo WV, Chen H, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Lesser IM, Kornstein SG, Wisniewski SR, Rush AJ, Shelton RC.

J Affect Disord. 2011 Oct;133(3):467-76. doi: 10.1016/j.jad.2011.04.032. Epub 2011 May 23.

PMID:
21601287
8.

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR.

Am J Psychiatry. 2011 Jul;168(7):689-701. doi: 10.1176/appi.ajp.2011.10111645. Epub 2011 May 2.

PMID:
21536692
9.

Religiosity and treatment response to antidepressant medication: A prospective multi-site clinical trial.

Schettino JR, Olmos NT, Myers HF, Joseph NT, Poland RE, Lesser IM.

Ment Health Relig Cult. 2011 Jan 1;14(8):805-818. Epub 2011 Jun 13.

10.

Ethnic differences in antidepressant response: a prospective multi-site clinical trial.

Lesser IM, Myers HF, Lin KM, Bingham Mira C, Joseph NT, Olmos NT, Schettino J, Poland RE.

Depress Anxiety. 2010;27(1):56-62. doi: 10.1002/da.20619.

11.

Identifying risk for attrition during treatment for depression.

Warden D, Trivedi MH, Wisniewski SR, Lesser IM, Mitchell J, Balasubramani GK, Fava M, Shores-Wilson K, Stegman D, Rush AJ.

Psychother Psychosom. 2009;78(6):372-9. doi: 10.1159/000235977. Epub 2009 Sep 8.

12.

Income and attrition in the treatment of depression: a STAR*D report.

Warden D, Rush AJ, Wisniewski SR, Lesser IM, Thase ME, Balasubramani GK, Shores-Wilson K, Nierenberg AA, Trivedi MH.

Depress Anxiety. 2009;26(7):622-33. doi: 10.1002/da.20541.

PMID:
19582825
13.

An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.

Leuchter AF, Lesser IM, Trivedi MH, Rush AJ, Morris DW, Warden D, Fava M, Wisniewski SR, Luther JF, Perales M, Gaynes BN, Stewart JW.

J Psychiatr Pract. 2008 Sep;14(5):271-80. doi: 10.1097/01.pra.0000336754.19566.65.

14.

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

Warden D, Rush AJ, Wisniewski SR, Lesser IM, Kornstein SG, Balasubramani GK, Thase ME, Preskorn SH, Nierenberg AA, Young EA, Shores-Wilson K, Trivedi MH.

Int J Neuropsychopharmacol. 2009 May;12(4):459-73. doi: 10.1017/S1461145708009073. Epub 2008 Jul 9.

15.

Ethnicity/race and outcome in the treatment of depression: results from STAR*D.

Lesser IM, Castro DB, Gaynes BN, Gonzalez J, Rush AJ, Alpert JE, Trivedi M, Luther JF, Wisniewski SR.

Med Care. 2007 Nov;45(11):1043-51.

PMID:
18049344
16.

Insured and non-insured depressed outpatients: how do they compare?

Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Fava M, Rush AJ.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):73-82.

PMID:
17612846
17.

Has the rolling uterus finally gathered moss? Somatization and malingering of cognitive deficit in six cases of "toxic mold" exposure.

Stone DC, Boone KB, Back-Madruga C, Lesser IM.

Clin Neuropsychol. 2006 Dec;20(4):766-85.

PMID:
16980261
18.

Characteristics of insured and noninsured outpatients with depression in STAR(*)D.

Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Petersen T, Stegman D, Rush AJ.

Psychiatr Serv. 2005 Aug;56(8):995-1004.

PMID:
16088018
19.

Base rates of "impaired" neuropsychological test performance among healthy older adults.

Palmer BW, Boone KB, Lesser IM, Wohl MA.

Arch Clin Neuropsychol. 1998 Aug;13(6):503-11.

PMID:
14590634
20.

Apolipoprotein-E and white-matter hyperintensities in late-life depression.

Lavretsky H, Lesser IM, Wohl M, Miller BL, Mehringer CM, Vinters HV.

Am J Geriatr Psychiatry. 2000 Summer;8(3):257-61.

PMID:
10910427
21.

REM sleep in depression is influenced by ethnicity.

Poland RE, Rao U, Lutchmansingh P, McCracken JT, Lesser IM, Edwards C, Ott GE, Lin KM.

Psychiatry Res. 1999 Nov 8;88(2):95-105.

PMID:
10622346
22.

Clinical and neuroradiologic features associated with chronicity in late-life depression.

Lavretsky H, Lesser IM, Wohl M, Miller BL, Mehringer CM.

Am J Geriatr Psychiatry. 1999 Fall;7(4):309-16.

PMID:
10521163
23.

Relationship of age, age at onset, and sex to depression in older adults.

Lavretsky H, Lesser IM, Wohl M, Miller BL.

Am J Geriatr Psychiatry. 1998 Summer;6(3):248-56.

PMID:
9659957
24.

Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.

Swartz JR, Miller BL, Lesser IM, Darby AL.

J Clin Psychiatry. 1997 May;58(5):212-6. Erratum in: J Clin Psychiatry 1997 Jun;58(6):275.

PMID:
9184615
25.

Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects.

Poland RE, McCracken JT, Lutchmansingh P, Lesser IM, Tondo L, Edwards C, Boone KB, Lin KM.

Biol Psychiatry. 1997 May 1;41(9):929-38.

PMID:
9110098
26.

Behavioral phenomenology in Alzheimer's disease, frontotemporal dementia, and late-life depression: a retrospective analysis.

Swartz JR, Miller BL, Lesser IM, Booth R, Darby A, Wohl M, Benson DF.

J Geriatr Psychiatry Neurol. 1997 Apr;10(2):67-74.

PMID:
9188022
27.

Neuropsychological deficits among older depressed patients with predominantly psychological or vegetative symptoms.

Palmer BW, Boone KB, Lesser IM, Wohl MA, Berman N, Miller BL.

J Affect Disord. 1996 Nov 4;41(1):17-24.

PMID:
8938201
28.

Cognition and white matter hyperintensities in older depressed patients.

Lesser IM, Boone KB, Mehringer CM, Wohl MA, Miller BL, Berman NG.

Am J Psychiatry. 1996 Oct;153(10):1280-7.

PMID:
8831435
29.

Brain imaging, antidepressants, and ethnicity: preliminary observations.

Lesser IM, Smith MW, Wohl M, Mena RN, Mehringer CM, Lin KM.

Psychopharmacol Bull. 1996;32(2):235-42.

PMID:
8783893
30.

The evolving science of pharmacogenetics: clinical and ethnic perspectives.

Lin KM, Poland RE, Wan YJ, Smith MW, Lesser IM.

Psychopharmacol Bull. 1996;32(2):205-17. Review.

PMID:
8783890
31.

Bilateral cerebral pathology and the genesis of delusional misidentification.

Silva JA, Leong GB, Lesser IM, Boone KB.

Can J Psychiatry. 1995 Oct;40(8):498-9. No abstract available.

PMID:
8681277
32.

Reduction of cerebral blood flow in older depressed patients.

Lesser IM, Mena I, Boone KB, Miller BL, Mehringer CM, Wohl M.

Arch Gen Psychiatry. 1994 Sep;51(9):677-86.

PMID:
8080344
33.

Late-onset depression with white matter lesions.

Lesser IM, Hill-Gutierrez E, Miller BL, Boone KB.

Psychosomatics. 1993 Jul-Aug;34(4):364-7. No abstract available.

PMID:
8351313
34.

Frontal lobe cognitive functions in aging: methodologic considerations.

Boone KB, Miller BL, Lesser IM.

Dementia. 1993 May-Aug;4(3-4):232-6. Review.

PMID:
8401797
35.

Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics.

Miller BL, Chang L, Mena I, Boone K, Lesser IM.

Dementia. 1993 May-Aug;4(3-4):204-13.

PMID:
8401793
36.

Wisconsin Card Sorting Test performance in healthy, older adults: relationship to age, sex, education, and IQ.

Boone KB, Ghaffarian S, Lesser IM, Hill-Gutierrez E, Berman NG.

J Clin Psychol. 1993 Jan;49(1):54-60.

PMID:
8425935
37.

Brain imaging in late-life schizophrenia and related psychoses.

Lesser IM, Miller BL, Swartz JR, Boone KB, Mehringer CM, Mena I.

Schizophr Bull. 1993;19(4):773-82.

PMID:
8303226
38.

Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.

Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.

Am J Psychiatry. 1992 Nov;149(11):1556-62.

PMID:
1415824
39.

Alexithymia and the ECA study.

Lesser IM.

Am J Psychiatry. 1992 Sep;149(9):1281-2. No abstract available.

PMID:
1503153
40.

Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects.

Rubin RT, Heist EK, McGeoy SS, Hanada K, Lesser IM.

Arch Gen Psychiatry. 1992 Jul;49(7):558-67. Erratum in: Arch Gen Psychiatry 1992 Oct;49(10):781.

PMID:
1627047
41.

Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect.

Boone KB, Miller BL, Lesser IM, Mehringer CM, Hill-Gutierrez E, Goldberg MA, Berman NG.

Arch Neurol. 1992 May;49(5):549-54.

PMID:
1580819
42.

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.

Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R.

J Clin Psychopharmacol. 1992 Apr;12(2):96-103.

PMID:
1573046
43.

Late-onset psychotic disorder, not otherwise specified: clinical and neuroimaging findings.

Lesser IM, Jeste DV, Boone KB, Harris MJ, Miller BL, Heaton RK, Hill-Gutierrez E.

Biol Psychiatry. 1992 Feb 15;31(4):419-23. No abstract available.

PMID:
1558906
44.

Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics.

Miller BL, Cummings JL, Villanueva-Meyer J, Boone K, Mehringer CM, Lesser IM, Mena I.

Neurology. 1991 Sep;41(9):1374-82.

PMID:
1891084
45.

Brain injury and cognitive function in late-onset psychotic depression.

Lesser IM, Miller BL, Boone KB, Hill-Gutierrez E, Mehringer CM, Wong K, Mena I.

J Neuropsychiatry Clin Neurosci. 1991 Winter;3(1):33-40.

PMID:
7580170
46.

Brain lesions and cognitive function in late-life psychosis.

Miller BL, Lesser IM, Boone KB, Hill E, Mehringer CM, Wong K.

Br J Psychiatry. 1991 Jan;158:76-82.

PMID:
2015454
47.
48.

Serum haloperidol and desipramine concentrations and the treatment of psychotic depression: two case reports.

Lin KM, Poland RE, Fu P, Nuccio I, Lesser IM.

J Nerv Ment Dis. 1989 Jul;177(7):431-2. No abstract available.

PMID:
2746195
49.

Brain white-matter lesions and psychosis.

Miller BL, Lesser IM, Boone K, Goldberg M, Hill E, Miller MH, Benson DF, Mehringer M.

Br J Psychiatry. 1989 Jul;155:73-8.

PMID:
2605435

Supplemental Content

Loading ...
Support Center